Table 4. Multiplex Assays Authorized for Simultaneous Detection of Influenza Viruses and SARS-CoV-2 by FDA




High CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument Influenza A, Influenza B SARS-CoV-2 NPS, NPW, NPA, NS, NA, TS, sputum, TA, BAL 4 hours High, Moderate BioFire Diagnostics, LLC BioFire Respiratory Panel 2.1 (RP2.1) FILMARRAY® 2.0 and FILMARRAY® TORCH systems Influenza A, A(H1), A(H1pdm09), A(H3), Influenza B SARS-CoV-2,

Adenovirus, Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43, Human Metapneumovirus, Human Rhinovirus/Enterovirus, Parainfluenza Virus 1, Parainfluenza Virus 2, Parainfluenza Virus 3, Parainfluenza Virus 4, Respiratory Syncytial Virus

NPS 1 hour High, Moderate QIAGEN QIAstat-Dx Respiratory SARS-CoV-2 Panel QIAstat Dx Analyzer System 1.0 Influenza A, Influenza A H1, Influenza A H3, Influenza A H1N1/pdm09, Influenza B, SARS-CoV-2, Adenovirus, Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43, SARS-CoV-2, Human Metapneumovirus A+B, Parainfluenza virus 1, Parainfluenza virus 2, Parainfluenza virus 3, Parainfluenza virus 4, Rhinovirus/Enterovirus, Respiratory Syncytial Virus A+B NPS in universal transport media 1 hour

Source link

Author: Admin

Leave a Reply

Your email address will not be published.